Appears on
Articles4
Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s
Clinical-stage Kalohexis is readying a public listing to support its obesity and cancer cachexia treatments.
0
Fierce Biotech1d agoAs US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
As U.S. lawmakers continue to scrutinize the consequences of China’s expanding role in biotech innovation, industry insiders have been left debating how they can navigate this shifting landscape—or even whether biotechs should abandon China altogether.
0
Fierce Biotech1d agoWhitehawk swoops in for five ADCs via development deal with China's Biocytogen
Biocytogen and Whitehawk Therapeutics are joining forces to develop bispecific antibody-drug conjugates using Biocytogen's discovery platform.
0
Fierce Biotech1d agoCaidya and Simbec-Orion unite in global CRO combo
Contract research organizations (CROs) Caidya and Simbec-Orion have united to create a new platform aimed at helping drug development programs accelerate and scale.
0
Fierce Biotech1d ago